ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1775

Childhood-onset Sjögren Disease Has an Altered Peripheral Blood Immune Landscape Compared to Adult-onset Disease Characterized by Activated CD4+ T-cells Which Could Drive B-cell Dysregulation

Junjie Peng, Lucia Martin-Gutierrez, George Robinson, Elizabeth Jury and Coziana Ciurtin, University College London, London, United Kingdom

Meeting: ACR Convergence 2024

Keywords: B-Lymphocyte, immunology, Sjögren's syndrome, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Childhood-onset Sjögren Disease (cSjD) is a rare, poorly understood autoimmune rheumatic disease with onset before 18 years. Differences in clinical presentation compared to adults/lack of evidence-based therapies, warrant research into cSjD pathogenesis. We aimed to characterize the peripheral blood immunological landscape of cSjD.

Methods: A pilot cross-sectional study of the peripheral blood immune phenotype was conducted using conventional flow cytometry methodology/analysis of children and adolescents with cSjD (N=10; mean age (range)=18 (16-21) years; all female; mean age (range) at diagnosis=14 (12-17) years; off steroids/biologic treatment naïve) compared to age/sex-matched healthy controls (cHCs; N=10; mean age (range)=18 (15-25) years; all female). The identified phenotype was further explored using 30-feature spectral flow cytometry in a larger cohort of cSjD (mean age (range)=21 (17-30) years; all female, mean age (range) at diagnosis=15 (7-17) years) and cHCs (mean age (range)=19 (15-27) years; all female) (N=19/group) using unsupervised dimensionality reduction (UMAP)/clustering (FlowSOM) analysis. Serum cytokines were assessed by Cytometric Bead Array/Luminex.

Results: CD4+ T-cell and B-cell populations were significantly dysregulated in young people with cSjD compared with matched cHCs using conventional flow cytometry analysis, characterized by elevated CD4+ effector memory (EM, p=0.01), terminally differentiated CD4+EMRA (p=0.0002) naïve (p=0.01) and activated (p=0.008) B-cell populations and reduced CD4+ central memory T-cells (p=< 0.0001) and memory B-cells (p=< 0.02). The wider immune landscape of cSjD vs CHCs was further explored using unsupervised high-parameter spectral flow cytometry. Multiple T-cell and B-cell clusters were differentially regulated in cSjD patients compared to cHCs. Notably, two CD45RA- memory T-cells clusters expressed high levels of PD-1, CXCR3 and ICOS, suggesting an activated T-follicular helper-1 phenotype; while other clusters had elevated PD-1 and/or ICOS. This pro-inflammatory and activated T-cell phenotype was supported by increased production of IL-6 by CD4+ T-cells (p=0.04) and increased serum IL-6 levels (p=0.02) in young people with cSjD vs cHCs. One B-cell cluster was significantly upregulated in cSjD (p=0.0001), with high levels of CD24 and CD38, suggesting a transitional B-cell phenotype. This cluster was significantly positively correlated with activated T cell clusters. Finally, cytokines associated with B-cell activation, IL-10 (p=0.01) and APRIL (p=0.0007), and immune cell trafficking, CCL8 (p=0.03), were also increased in cSjD, suggesting immune dysregulation and increased chemotactic activity.

Conclusion: While adult-onset SjD is characterized by peripheral CD4+ T-cell lymphopenia, we detected an opposite trend towards significant expansion of CD4+ T-cell subset frequencies in cSjD. This could have significant therapeutic implications, suggesting that cSjD may recapitulate the early phase of the corresponding adult disease phenotype, when treatments with T-cell targeted (such as abatacept, low dose IL2) or broader (such as leflunomide or cyclosporine A) effects could be beneficial.  


Disclosures: J. Peng: None; L. Martin-Gutierrez: None; G. Robinson: None; E. Jury: None; C. Ciurtin: None.

To cite this abstract in AMA style:

Peng J, Martin-Gutierrez L, Robinson G, Jury E, Ciurtin C. Childhood-onset Sjögren Disease Has an Altered Peripheral Blood Immune Landscape Compared to Adult-onset Disease Characterized by Activated CD4+ T-cells Which Could Drive B-cell Dysregulation [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/childhood-onset-sjogren-disease-has-an-altered-peripheral-blood-immune-landscape-compared-to-adult-onset-disease-characterized-by-activated-cd4-t-cells-which-could-drive-b-cell-dysregulation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/childhood-onset-sjogren-disease-has-an-altered-peripheral-blood-immune-landscape-compared-to-adult-onset-disease-characterized-by-activated-cd4-t-cells-which-could-drive-b-cell-dysregulation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology